Get started

Intercept Pharmaceuticals, Inc

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

ICPT chart

Key stats

Market capitalization
463.56MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
1.69
Basic EPS (TTM)
6.35USD

About Intercept Pharmaceuticals, Inc

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Jerome B. Durso
Website
interceptpharma.com
Headquarters
Morristown
Employees
341
Founded
2002
ISIN
US45845P1084

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.

Ideas

ICPT - PDUFA date on 22/06/2023This is not a financial advice! Upcoming catalysts on 18/5/2023 and 22/06/2023 We can accumulate here in the 13 zone, we could drop even furhter to support to the 11 zone. I assume that wie are seeing a pre run up into the events. One strategy could be only playing that and sell before the news.
Long
2
Alternate Bat/BearishShort interest is a bit over 45% depending on where you look. Some would calculate targets at these levels. Bearish Harami right now that can change by close. When short is this high, sometimes it can cause a squeeze. Not a frequent occurrence but it does happen. No recommendation. A short squ
ICPT has triple confirmed a bottom. There are two high gaps it needs to fill. These gaps are on the daily, and,... do not get filed over night (which comes from OTC moves/"bets"). By mathematical law you cannot add a level or volume without it being on the permanent record (LEDGER)... There is 1 perfect ledger that will fix all of thi
Long
ICPT LongTry to buy historical low Downtrend Wedge near breakout RSI Divergence WR>-80 (my scripts: Williams %R two lines) Entry 18 Stop 15 Target 28 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.45Fabulous
Learn more
OANDA
OANDA
Forex
4.52Great
Learn more
FOREX.com
FOREX.com
Forex
4.37Fabulous
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more